These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2833185)

  • 1. Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy.
    Doherty M; Richards N; Hornby J; Powell R
    Ann Rheum Dis; 1988 Mar; 47(3):190-7. PubMed ID: 2833185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the complement split product C3dg in synovial fluid as a possible diagnostic guide in inflammatory arthropathies.
    Michel BA; Schlumpf U; Simmler F
    J Rheumatol; 1989 Sep; 16(9):1201-4. PubMed ID: 2810276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex.
    Mollnes TE; Lea T; Mellbye OJ; Pahle J; Grand O; Harboe M
    Arthritis Rheum; 1986 Jun; 29(6):715-21. PubMed ID: 3718564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial fluid calcium pyrophosphate dihydrate crystals and alizarin red positivity: analysis of 3000 samples.
    Hamilton E; Pattrick M; Hornby J; Derrick G; Doherty M
    Br J Rheumatol; 1990 Apr; 29(2):101-4. PubMed ID: 2157516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints.
    Pattrick M; Hamilton E; Hornby J; Doherty M
    Ann Rheum Dis; 1991 Apr; 50(4):214-8. PubMed ID: 1851409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
    Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
    Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of immunoglobulins and complement factors in synovial fluid and serum in rheumatoid arthritis, seronegative spondyloarthropathies and osteoarthritis: pathophysiology and retrospective analysis of clinical value].
    Möller B; Kessler U; Braner A; Dielehner N; Kaltwasser JP
    Z Rheumatol; 2002 Feb; 61(1):48-57. PubMed ID: 11974492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis.
    Mollnes TE; Paus A
    Arthritis Rheum; 1986 Nov; 29(11):1359-64. PubMed ID: 3778542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
    Brodeur JP; Ruddy S; Schwartz LB; Moxley G
    Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C3 cleavage product in synovial fluids detected by immunofixation.
    Partsch G; Bauer K; Bröll H; Petera P; Dunky A; Merétey K
    Z Rheumatol; 1991; 50(2):82-5. PubMed ID: 1872046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid.
    Høgåsen K; Mollnes TE; Harboe M; Götze O; Hammer HB; Oppermann M
    J Rheumatol; 1995 Jan; 22(1):24-8. PubMed ID: 7535360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis.
    Olmez U; Garred P; Mollnes TE; Harboe M; Berntzen HB; Munthe E
    Scand J Rheumatol; 1991; 20(3):183-9. PubMed ID: 2068540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does acute synovitis (pseudogout) occur in patients with chronic pyrophosphate arthropathy (pseudo-osteoarthritis)?
    Schlesinger N; Hassett AL; Neustadter L; Schumacher HR
    Clin Exp Rheumatol; 2009; 27(6):940-4. PubMed ID: 20149309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrate in synovial fluid and its relation to inflammation and crystal presence.
    Van Linthoudt D; Salani I; Zender R; Locatelli P; Ott H; Schumacher HR
    J Rheumatol; 1996 Mar; 23(3):502-5. PubMed ID: 8832992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inorganic pyrophosphate pool size and turnover rate in arthritic joints.
    Camerlain M; McCarty DJ; Silcox DC; Jung A
    J Clin Invest; 1975 Jun; 55(6):1373-81. PubMed ID: 166095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis.
    Moxley G; Ruddy S
    Arthritis Rheum; 1985 Oct; 28(10):1089-95. PubMed ID: 3876836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin.
    Hasselbacher P
    Arthritis Rheum; 1979 Mar; 22(3):243-50. PubMed ID: 105740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.